Vardenafil Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Vardenafil Hydrochloride
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Vardenafil Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 6 USDMF, 5 CEP/COS, 2 JDMF, 8 EU WC, 2 KDMF, 14 NDC API, 20 Listed Suppliers, $ API Reference Price

26 API Suppliers
6 USDMF
5 CEP/COS
2 JDMF
8 EU WC
2 KDMF
14 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

100 FDF Dossiers, 32 FDA Orange Book, 39 Europe, 6 Canada, 3 South Africa, 20 Listed Dossiers

100 FDF Dossiers
32 FDA Orange Book
39 Europe
6 Canada
3 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 3 DKSH, 2 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 3 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 21 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 The Dow Chemical Company, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

45 Coating Systems & Additives, 40 Fillers, Diluents & Binders, 23 Controlled & Modified Release, 18 Direct Compression, 17 Taste Masking, 16 Thickeners and Stabilizers, 15 Chewable & Orodispersible Aids, 14 Film Formers & Plasticizers, 11 Granulation, 10 Lubricants & Glidants, 10 Co-Processed Excipients, 9 Disintegrants & Superdisintegrants, 8 Parenteral, 7 Topical, 6 Solubilizers, 5 Empty Capsules, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Coloring Agents, 2 Rheology Modifiers, 1 Soft Gelatin

45 Coating Systems & Additives
40 Fillers, Diluents & Binders
23 Controlled & Modified Release
18 Direct Compression
17 Taste Masking
16 Thickeners and Stabilizers
15 Chewable & Orodispersible Aids
14 Film Formers & Plasticizers
11 Granulation
10 Lubricants & Glidants
10 Co-Processed Excipients
9 Disintegrants & Superdisintegrants
8 Parenteral
7 Topical
6 Solubilizers
5 Empty Capsules
4 Emulsifying Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Coloring Agents
2 Rheology Modifiers
1 Soft Gelatin

DIGITAL CONTENT

18 NEWS #PharmaBuzz

18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 26 Finished Drug Prices, 2 Annual Reports

1 US Medicaid Prescriptions
26 Finished Drug Prices
2 Annual Reports

MARKET PLACE

12 APIs

12 APIs

PATENTS & EXCLUSIVITIES

5 US Patents, 5 Health Canada Patents

5 US Patents
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 USP, 11 Others

2 USP
11 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,146 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 4Bayer Inc.

02 1Bayer Inc., Healthcare Division

filter Patent Reset all filters

5 All

01 42309332

02 12599617

filter Product Reset all filters

5 All

01 5Vardenafil Hydrochloride

filter Dosage Reset all filters

5 All

01 2Disintegrating Tablet

02 3Tablet

filter Exp Date Reset all filters

5 All

01 42018-10-31

02 12026-02-16

Product Main Page

01

Bayer Inc., Healthcare Division

Vardenafil Hydrochloride

PharmScience R&D

Not Confirmed

Bayer Inc., Healthcare Division

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Bayer Inc.

Vardenafil Hydrochloride

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 10 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Bayer Inc.

Vardenafil Hydrochloride

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : LEVITRA

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 20 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Bayer Inc.

Vardenafil Hydrochloride

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Vardenafil Hydrochloride

Brand Name : STAXYN

Patent Number : 2309332

Filing Date : 1998-10-31

Strength per Unit : 10 mg

Dosage Form : Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2018-10-31

Date Granted : 2002-12-03

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Bayer Inc.

Vardenafil Hydrochloride

PharmScience R&D

Not Confirmed

Bayer Inc.

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-16

Date Granted : 2012-01-10

Vardenafil Hydrochloride

Brand Name : STAXYN

Patent Number : 2599617

Filing Date : 2006-02-16

Strength per Unit : 10 mg

Dosage Form : Disintegrating Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2026-02-16

Date Granted : 2012-01-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!